BCM
WST icon

Brookstone Capital Management’s West Pharmaceutical WST Stock Holding History

Brookstone Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-776
Closed -$254K – 1070
2024
Q4 		$254K Sell
776
-25
-3% -$7.87K ﹤0.01% 873
2024
Q3 		$240K Sell
801
-32
-4% -$9.8K ﹤0.01% 905
2024
Q2 		$272K Buy
833
+23
+3% +$8.13K ﹤0.01% 817
2024
Q1 		$321K Sell
810
-4,131
-84% -$1.53M 0.01% 739
2023
Q4 		$1.74M Sell
4,941
-1,914
-28% -$677K 0.03% 353
2023
Q3 		$2.53M Sell
6,855
-34
-0.5% -$13.1K 0.06% 270
2023
Q2 		$2.56M Buy
6,889
+16
+0.2% +$5.72K 0.05% 274
2023
Q1 		$2.49M Sell
6,873
-251
-4% -$73.3K 0.05% 288
2022
Q4 		$1.66M Buy
7,124
+34
+0.5% +$8.06K 0.03% 339
2022
Q3 		$1.7M Sell
7,090
-45
-0.6% -$13.7K 0.04% 309
2022
Q2 		$2.27M Sell
7,135
-50
-0.7% -$16.3K 0.05% 268
2022
Q1 		$2.86M Sell
7,185
-1,114
-13% -$436K 0.06% 244
2021
Q4 		$3.24M Buy
8,299
+7,117
+602% +$3.06M 0.06% 210
2021
Q3 		$476K Buy
+1,182
New +$498K 0.01% 510
2020
Q1 		– Sell
-1,455
Closed -$219K – 437
2019
Q4 		$219K Sell
1,455
-1,110
-43% -$162K 0.01% 380
2019
Q3 		$364K Sell
2,565
-1,106
-30% -$152K 0.02% 312
2019
Q2 		$459K Sell
3,671
-1,102
-23% -$130K 0.03% 285
2019
Q1 		$526K Buy
+4,773
New +$496K 0.03% 209
2018
Q4 		– Sell
-4,620
Closed -$570K – 406
2018
Q3 		$570K Sell
4,620
-1,218
-21% -$137K 0.04% 228
2018
Q2 		$580K Buy
+5,838
New +$537K 0.05% 185

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Brookstone Capital Management's WST Position: Q1 2025 in Review

Brookstone Capital Management sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 776 shares — an estimated $254K sold.

Brookstone Capital Management first reported a position in WST in Q2 2018 and held it in 20 quarters. The position peaked at $3.24M in Q4 2021. 715 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Brookstone Capital Management reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Brookstone Capital Management sold 776 West Pharmaceutical shares in Q1 2025, an estimated $254K.
  • Brookstone Capital Management first reported a position in West Pharmaceutical in Q2 2018 and held it in 20 quarters.
  • Brookstone Capital Management's West Pharmaceutical position peaked at $3.24M in Q4 2021.
  • 715 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Brookstone Capital Management's 13F filing for Q1 2025, filed 29 Apr 2025.